Wendy Diller

Senior Writer/Market Analyst

20 Years of Experience

About

Wendy writes on the medical devices and clinical diagnostics sectors, where she focuses on orthopedics/spine, molecular diagnostics and personalized medicine, clinical genomics, womens’ health/ femtech, and reimbursement/commercial strategy and innovation related to these specialties. She welcomes and encourages ideas and input from members of the MedTech Strategist Community.

Her career spans more than 20+ years as a top writer and manager focused on qualitative analysis of the global life sciences industry. She is Chair of Young Women in Bio Metro NY, an organization devoted to encouraging secondary students in the NY area to pursuit STEM careers and on the board of the Columbia Business School of Alumni Club NY

Specialties
Publications
Articles from Wendy Diller:
Read all from this author
Coronavirus Analysis

Medtech in 2021: Equipping for a Post-COVID-19 Rebound

  • February 02, 2021
  • Wendy Diller
  • MedTech Strategist

In 2021, medtech will grapple with ways to capture the pandemic rebound opportunity through value-adding new technologies and responsiveness to the complexities and diversity of the shifting US healthcare system. In late January, a panel of experts spoke with MedTech Strategist about these challenges.

Read Article